Search

Your search keyword '"Alicia Lacoma"' showing total 118 results

Search Constraints

Start Over You searched for: Author "Alicia Lacoma" Remove constraint Author: "Alicia Lacoma"
118 results on '"Alicia Lacoma"'

Search Results

1. Bacille Calmette-Guérin vaccination to prevent febrile and respiratory illness in adults (BRACE): secondary outcomes of a randomised controlled phase 3 trialResearch in context

2. Measurement of IFN-γ and IL-2 for the assessment of the cellular immunity against SARS-CoV-2

3. Specific and off-target immune responses following COVID-19 vaccination with ChAdOx1-S and BNT162b2 vaccines—an exploratory sub-study of the BRACE trialResearch in context

4. Global mortality and readmission rates following COPD exacerbation-related hospitalisation: a meta-analysis of 65 945 individual patients

5. Bacillus Calmette-Guérin vaccination for protection against recurrent herpes labialis: a nested randomised controlled trialResearch in context

6. Gut to lung translocation and antibiotic mediated selection shape the dynamics of Pseudomonas aeruginosa in an ICU patient

7. Strain-specific interspecies interactions between co-isolated pairs of Staphylococcus aureus and Pseudomonas aeruginosa from patients with tracheobronchitis or bronchial colonization

8. Advances in diagnostic tools for respiratory tract infections: from tuberculosis to COVID-19 – changing paradigms?

9. BCG vaccination to reduce the impact of COVID-19 in healthcare workers: Protocol for a randomised controlled trial (BRACE trial)

10. E-cigarettes: Effects in phagocytosis and cytokines response against Mycobacterium tuberculosis.

11. IFNΛ3/4 locus polymorphisms and IFNΛ3 circulating levels are associated with COPD severity and outcomes

12. Impact of Host Genetics and Biological Response Modifiers on Respiratory Tract Infections

13. Study of CD27 and CCR4 Markers on Specific CD4+ T-Cells as Immune Tools for Active and Latent Tuberculosis Management

14. Genotypic and Phenotypic Characterization of Staphylococcus aureus Isolates from the Respiratory Tract in Mechanically-Ventilated Patients

15. Bacteria in the respiratory tract—how to treat? Or do not treat?

16. Accessory gene regulator (Agr) functionality in Staphylococcus aureus derived from lower respiratory tract infections.

17. Value of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease

18. Evaluation of interferon-gamma release assays in the diagnosis of recent tuberculosis infection in health care workers.

19. Apoptosis, Toll-like, RIG-I-like and NOD-like Receptors Are Pathways Jointly Induced by Diverse Respiratory Bacterial and Viral Pathogens

20. Measuring T-Cell Responses against SARS-CoV-2 Is of Utility for Disease and Vaccination Management

21. Development and Evaluation of a Microarray Platform for Detection of Serum Antibodies Against Streptococcus pneumoniae Capsular Polysaccharides

22. Novel intracellular antibiotic delivery system against Staphylococcus aureus: cloxacillin-loaded poly(<scp>d</scp>,<scp>l</scp>-lactide-co-glycolide) acid nanoparticles

23. Direct Quantitative Immunochemical Analysis of Autoinducer Peptide IV for Diagnosing and Stratifying

24. Exploring the evolution and epidemiology of European CC1-MRSA-IV: tracking a multidrug-resistant community-associated meticillin-resistant

25. Cigarette smoke exposure redirects Staphylococcus aureus to a virulence profile associated with persistent infection

26. Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients

27. Microbiological Progress in Patients with Bronchial Infection with Pseudomonas aeruginosa Treated with Nebulised Colistin

28. Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia

29. Dysfunctional accessory gene regulator (agr) as a prognostic factor in invasive Staphylococcus aureus infection: a systematic review and meta-analysis

31. Bacterial etiology of community-acquired pneumonia in immunocompetent hospitalized patients and appropriateness of empirical treatment recommendations: an international point-prevalence study

32. Persistent Isolation of Staphylococcus aureus in Mechanically-ventilated Patients: Impact of Host–Pathogen Factors on Outcome

33. Use of IFN-γ and IP-10 detection in the diagnosis of latent tuberculosis infection in patients with inflammatory rheumatic diseases

34. Molecular Characterization of Mycobacterium tuberculosis Strains with TB-SPRINT

35. PyroTyping, a novel pyrosequencing-based assay for Mycobacterium tuberculosis genotyping

36. E-cigarettes: Effects in phagocytosis and cytokines response against Mycobacterium tuberculosis

37. Impact of Host Genetics and Biological Response Modifiers on Respiratory Tract Infections

38. Matryoshka-type gastro-resistant microparticles for the oral treatment of Mycobacterium tuberculosis

39. Bacteria in the respiratory tract—how to treat? Or do not treat?

40. Therapy with proton-pump inhibitors for gastroesophageal reflux disease does not reduce the risk for severe exacerbations in COPD

41. Extracellular matrix glycosaminoglycans can predict severity and outcome in COPD

42. Microbiological Progress in Patients with Bronchial Infection with Pseudomonas aeruginosa Treated with Nebulised Colistin

43. Serum levels of hyaluronic acid are associated with COPD severity and predict survival

44. Characterization of clinically relevant model bacterial strains of Pseudomonas aeruginosa for anti-biofilm testing of materials

45. IFNΛ3/4 locus polymorphisms and IFNΛ3 circulating levels are associated with COPD severity and outcomes

46. Treatment with long acting muscarinic antagonists stimulates serum levels of irisin in patients with COPD

47. Diagnostic accuracy study of multiplex PCR for detecting tuberculosis drug resistance

48. AID TB resistance line probe assay for rapid detection of resistant Mycobacterium tuberculosis in clinical samples

49. Irisin is associated with clinical outcomes and up-regulated by long-acting anticholinergics in COPD

50. Hyaluronic acid, heparan sulfate and chondroitin sulfate are altered during exacerbations of COPD

Catalog

Books, media, physical & digital resources